CN111771873B - Method for improving quality of thawed pig sperms - Google Patents
Method for improving quality of thawed pig sperms Download PDFInfo
- Publication number
- CN111771873B CN111771873B CN202010745843.XA CN202010745843A CN111771873B CN 111771873 B CN111771873 B CN 111771873B CN 202010745843 A CN202010745843 A CN 202010745843A CN 111771873 B CN111771873 B CN 111771873B
- Authority
- CN
- China
- Prior art keywords
- parts
- semen
- sodium
- freezing
- thin tube
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000000034 method Methods 0.000 title claims abstract description 35
- 210000000582 semen Anatomy 0.000 claims abstract description 102
- 239000007788 liquid Substances 0.000 claims abstract description 51
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims abstract description 46
- 230000008014 freezing Effects 0.000 claims abstract description 43
- 238000007710 freezing Methods 0.000 claims abstract description 42
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 30
- SWUARLUWKZWEBQ-VQHVLOKHSA-N phenethyl caffeate Chemical compound C1=C(O)C(O)=CC=C1\C=C\C(=O)OCCC1=CC=CC=C1 SWUARLUWKZWEBQ-VQHVLOKHSA-N 0.000 claims abstract description 28
- SWUARLUWKZWEBQ-UHFFFAOYSA-N phenylethyl ester of caffeic acid Natural products C1=C(O)C(O)=CC=C1C=CC(=O)OCCC1=CC=CC=C1 SWUARLUWKZWEBQ-UHFFFAOYSA-N 0.000 claims abstract description 28
- 229920001612 Hydroxyethyl starch Polymers 0.000 claims abstract description 25
- 229940050526 hydroxyethylstarch Drugs 0.000 claims abstract description 25
- 229910052757 nitrogen Inorganic materials 0.000 claims abstract description 23
- 239000003085 diluting agent Substances 0.000 claims abstract description 22
- 238000002156 mixing Methods 0.000 claims abstract description 17
- 239000002244 precipitate Substances 0.000 claims abstract description 7
- 238000007789 sealing Methods 0.000 claims abstract description 7
- 238000007865 diluting Methods 0.000 claims abstract description 6
- 238000011049 filling Methods 0.000 claims abstract description 6
- 238000004321 preservation Methods 0.000 claims abstract description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 39
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 claims description 19
- WEEMDRWIKYCTQM-UHFFFAOYSA-N 2,6-dimethoxybenzenecarbothioamide Chemical compound COC1=CC=CC(OC)=C1C(N)=S WEEMDRWIKYCTQM-UHFFFAOYSA-N 0.000 claims description 15
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 15
- FCPVYOBCFFNJFS-LQDWTQKMSA-M benzylpenicillin sodium Chemical compound [Na+].N([C@H]1[C@H]2SC([C@@H](N2C1=O)C([O-])=O)(C)C)C(=O)CC1=CC=CC=C1 FCPVYOBCFFNJFS-LQDWTQKMSA-M 0.000 claims description 15
- 239000012153 distilled water Substances 0.000 claims description 15
- 239000008103 glucose Substances 0.000 claims description 15
- 229960002385 streptomycin sulfate Drugs 0.000 claims description 15
- DBGMKBNIXHAHKC-UHFFFAOYSA-N [Na]N.CCCCCCCCCCCCOS(O)(=O)=O Chemical compound [Na]N.CCCCCCCCCCCCOS(O)(=O)=O DBGMKBNIXHAHKC-UHFFFAOYSA-N 0.000 claims description 13
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 10
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 claims description 10
- 210000002969 egg yolk Anatomy 0.000 claims description 10
- 239000008101 lactose Substances 0.000 claims description 10
- 230000003204 osmotic effect Effects 0.000 claims description 8
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 claims description 5
- 238000011534 incubation Methods 0.000 claims description 5
- 239000001103 potassium chloride Substances 0.000 claims description 5
- 235000011164 potassium chloride Nutrition 0.000 claims description 5
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 claims description 5
- 229960000999 sodium citrate dihydrate Drugs 0.000 claims description 5
- 210000005239 tubule Anatomy 0.000 claims description 4
- 238000001802 infusion Methods 0.000 claims description 2
- 238000011067 equilibration Methods 0.000 claims 1
- WWVKQTNONPWVEL-UHFFFAOYSA-N caffeic acid phenethyl ester Natural products C1=C(O)C(O)=CC=C1C=CC(=O)OCC1=CC=CC=C1 WWVKQTNONPWVEL-UHFFFAOYSA-N 0.000 abstract description 24
- 230000000694 effects Effects 0.000 abstract description 11
- 239000000203 mixture Substances 0.000 abstract description 9
- 210000000170 cell membrane Anatomy 0.000 abstract description 7
- 230000002195 synergetic effect Effects 0.000 abstract description 2
- 239000000243 solution Substances 0.000 description 24
- 210000004027 cell Anatomy 0.000 description 10
- 230000006378 damage Effects 0.000 description 8
- 108020004414 DNA Proteins 0.000 description 7
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 7
- 239000002953 phosphate buffered saline Substances 0.000 description 7
- 239000013078 crystal Substances 0.000 description 6
- 102000002322 Egg Proteins Human genes 0.000 description 5
- 108010000912 Egg Proteins Proteins 0.000 description 5
- 235000013345 egg yolk Nutrition 0.000 description 5
- 239000011521 glass Substances 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 238000010257 thawing Methods 0.000 description 5
- 230000000052 comparative effect Effects 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 239000012528 membrane Substances 0.000 description 4
- 239000003642 reactive oxygen metabolite Substances 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 241000282887 Suidae Species 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 230000008021 deposition Effects 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 230000009027 insemination Effects 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 230000019100 sperm motility Effects 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- GAWIXWVDTYZWAW-UHFFFAOYSA-N C[CH]O Chemical group C[CH]O GAWIXWVDTYZWAW-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 206010050208 Teratospermia Diseases 0.000 description 2
- 208000002312 Teratozoospermia Diseases 0.000 description 2
- 230000030120 acrosome reaction Effects 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 230000005284 excitation Effects 0.000 description 2
- 108010065337 fluorescein isothiocyanate-peanut agglutinin Proteins 0.000 description 2
- 238000012757 fluorescence staining Methods 0.000 description 2
- 210000002977 intracellular fluid Anatomy 0.000 description 2
- 230000003859 lipid peroxidation Effects 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 210000003463 organelle Anatomy 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 230000004792 oxidative damage Effects 0.000 description 2
- 230000037361 pathway Effects 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000004083 survival effect Effects 0.000 description 2
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 1
- 208000002679 Alveolar Bone Loss Diseases 0.000 description 1
- 229920000945 Amylopectin Polymers 0.000 description 1
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 1
- 206010007572 Cardiac hypertrophy Diseases 0.000 description 1
- 208000006029 Cardiomegaly Diseases 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- 206010020880 Hypertrophy Diseases 0.000 description 1
- 229920000881 Modified starch Polymers 0.000 description 1
- 239000004368 Modified starch Substances 0.000 description 1
- 108010057466 NF-kappa B Proteins 0.000 description 1
- 102000003945 NF-kappa B Human genes 0.000 description 1
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 1
- 102100028452 Nitric oxide synthase, endothelial Human genes 0.000 description 1
- 101710090055 Nitric oxide synthase, endothelial Proteins 0.000 description 1
- 239000005662 Paraffin oil Substances 0.000 description 1
- 108010046016 Peanut Agglutinin Proteins 0.000 description 1
- 241000241413 Propolis Species 0.000 description 1
- 102000014128 RANK Ligand Human genes 0.000 description 1
- 108010025832 RANK Ligand Proteins 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 102000000344 Sirtuin 1 Human genes 0.000 description 1
- 108010041191 Sirtuin 1 Proteins 0.000 description 1
- 206010000210 abortion Diseases 0.000 description 1
- 231100000176 abortion Toxicity 0.000 description 1
- 229960000583 acetic acid Drugs 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 230000009787 cardiac fibrosis Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229940074393 chlorogenic acid Drugs 0.000 description 1
- 235000001368 chlorogenic acid Nutrition 0.000 description 1
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 1
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 1
- XENVCRGQTABGKY-ZHACJKMWSA-N chlorohydrin Chemical compound CC#CC#CC#CC#C\C=C\C(Cl)CO XENVCRGQTABGKY-ZHACJKMWSA-N 0.000 description 1
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 238000005138 cryopreservation Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000001066 destructive effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000003722 extracellular fluid Anatomy 0.000 description 1
- 230000004720 fertilization Effects 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 1
- 238000013467 fragmentation Methods 0.000 description 1
- 238000006062 fragmentation reaction Methods 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 238000012214 genetic breeding Methods 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 230000013632 homeostatic process Effects 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 239000000815 hypotonic solution Substances 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 230000013011 mating Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 235000019426 modified starch Nutrition 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000008723 osmotic stress Effects 0.000 description 1
- 210000002997 osteoclast Anatomy 0.000 description 1
- 230000036542 oxidative stress Effects 0.000 description 1
- 201000001245 periodontitis Diseases 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 229940069949 propolis Drugs 0.000 description 1
- 238000005086 pumping Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- 230000008010 sperm capacitation Effects 0.000 description 1
- 230000021595 spermatogenesis Effects 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/02—Preservation of living parts
- A01N1/0205—Chemical aspects
- A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
- A01N1/0221—Freeze-process protecting agents, i.e. substances protecting cells from effects of the physical process, e.g. cryoprotectants, osmolarity regulators like oncotic agents
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Dentistry (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
The invention discloses a method for improving the quality of thawed pig sperms, which comprises the following operation steps: (1) diluting the collected qualified semen by a semen protection diluent, and then carrying out constant temperature balance treatment; (2) centrifuging the semen, adding the freezing base solution I into the obtained centrifugal precipitate, and carrying out constant-temperature balance treatment in a constant-temperature box after resuspension; (3) adding the freezing base liquid II into the mixture, uniformly mixing, filling the mixture into a thin tube, sealing, fumigating the mixture on liquid nitrogen or freezing the mixture by using a program freezer, and then putting the mixture into the liquid nitrogen for preservation; (4) when the semen is unfrozen, the thin tube is taken out of the liquid nitrogen, incubated in a water bath, added with the unfreezing diluent, and unfrozen. According to the invention, the caffeic acid phenethyl ester and the hydroxyethyl starch with corresponding concentrations are added into the frozen base solution I in a combined manner, and the synergistic effect of the caffeic acid phenethyl ester and the hydroxyethyl starch can effectively improve the activity, the plasma membrane integrity rate, the acrosome integrity rate and the DNA integrity rate of the thawed pig sperms and improve the quality of the frozen pig sperms.
Description
Technical Field
The invention relates to the technical field of pig sperm cryopreservation, in particular to a method for improving the quality of thawed pig sperm.
Background
With the rapid rise of the artificial insemination technology of the pigs, most of breeders in the pig industry adopt the method to breed the piglets so as to reduce the feeding cost of the boars. The semen is frozen and stored, so that the semen can be used without the limitation of time, place and objects, the use time and the use ratio of the semen of a superior boar are obviously increased, and the advantages enable the artificial insemination technology to be more popularized. Therefore, the frozen semen technique plays an important role.
The freezing preservation of the semen can effectively reserve the genetic breeding and germplasm resources of organisms. With the rapid development of the frozen pig semen production process and the artificial insemination technology, the breeding pigs bred by adopting the frozen semen are effectively improved in the aspects of conception rate and piglet delivery number, and are close to the mating level of fresh semen. However, the research on the pig semen freezing technology is still not completely mature due to the reasons of great difficulty in pig frozen semen production, low survival rate after frozen semen-thawing, low conception rate and the like.
The causes of the reduction of the quality of the pig sperms in the freezing process mainly comprise oxidative damage, cell infiltration damage, formation of ice crystals in cells and the like.
Oxidative damage in semen after freezing and thawing is mainly caused by excess Reactive Oxygen Species (ROS). Excess ROS mainly causes sperm lipid Peroxidation (lipid Peroxidation) and DNA fragmentation. The teratospermia rate is increased, the survival rate, the sperm movement rate and the like are reduced, and finally the conception rate and the birth rate are reduced, and the abortion rate and the fetal teratospermia rate are increased.
Cell osmotic damage and intracellular ice crystal formation are primarily due to the freezing rate. Research shows that at the temperature of minus 10 ℃, before the intracellular fluid of the sperm does not form ice crystals, the extracellular fluid of the sperm already forms the ice crystals, if the freezing rate is low, the water in the intracellular fluid of the sperm seeps out of the sperm, the osmotic pressure in the sperm rises, and the organelles and plasma membranes of the sperm are damaged due to high osmotic shrinkage; at this time, if the freezing rate is high, water in the sperm cell fluid cannot seep out, and the water in the sperm cell fluid forms ice crystals to damage sperm organelles and membranes.
In recent years, the prior art has studied in detail on external conditions affecting the quality of frozen semen, and the external conditions can be controlled to be within an appropriate range in the freezing process so as to minimize the influence caused by the external conditions; however, the internal damage mechanism is not clear, and how to avoid the quality loss of the pig sperms in the freezing process to the maximum degree becomes a technical problem to be solved.
Disclosure of Invention
The invention aims to provide a method for improving the quality of thawed pig sperms, which can obviously reduce the damages caused by oxidation damage, cell permeation damage and ice crystal formation in cells of the pig sperms in the freezing process. .
The invention is realized by the following technical scheme:
a method for improving the quality of thawed pig sperms comprises the following operation steps:
(1) diluting the collected qualified semen by a semen protection diluent, and then carrying out constant temperature balance treatment;
(2) centrifuging the semen, adding a freezing base solution I into the obtained centrifugal precipitate, and carrying out constant-temperature balance treatment in a constant-temperature box after resuspension, wherein the freezing base solution I is prepared from the following components in parts by weight: 300 parts of glucose, 300 parts of lactose, 400 parts of sodium bicarbonate, 10-15 parts of sodium bicarbonate, 5-7 parts of penicillin sodium, 8-12 parts of streptomycin sulfate, 2200 parts of yolk 1800, and 9000 parts of triple distilled water 7000, wherein the frozen base liquid I further comprises phenethyl caffeate and hydroxyethyl starch, the molar concentration of the phenethyl caffeate in the frozen base liquid I is 30-50 mu mol/L, and the mass fraction of the hydroxyethyl starch in the frozen base liquid I is 0.8-1.2%;
(3) adding frozen base liquid II to give final concentration of 4 × 108-8×108Mixing, filling into a thin tube, sealing, fumigating on liquid nitrogen or freezing by using a program freezing instrument, and then putting into liquid nitrogen for preservation;
(4) when the semen is unfrozen, the thin tube is taken out of the liquid nitrogen, incubated in a water bath kettle at 48-52 ℃ for 15-17s, transferred to a 36.9-37.1 ℃ preheated semen infusion bottle, and unfrozen.
Specifically, after semen is collected in the boar body, the semen is packaged in an incubator, and the semen is diluted by adopting a semen protection diluent within 2 hours.
Specifically, in the step (1), the qualified semen is selected by the following method: selecting slightly fishy and milky semen to perform microscopic examination, wherein the vitality of the semen is 90 percent, and the density of the semen is 2.0-4.0 hundred million/mL, so that the qualified semen is obtained.
Specifically, the semen protection diluent is prepared from the following components in parts by weight: 1.20-1.30 parts of ethylenediamine tetraacetic acid, 1.20-1.30 parts of sodium citrate dihydrate, 0.70-0.80 part of potassium chloride, 1.20-1.30 parts of sodium bicarbonate, 36.00-37.00 parts of glucose, 0.50-0.70 part of penicillin sodium, 0.80-1.20 parts of streptomycin sulfate and 1100 parts of triple distilled water, wherein the pH value of the semen protection diluent is 7.2-7.4, and the osmotic pressure is 300-320 mOsm/L.
Specifically, in the step (1), the specific operation of the constant temperature balance processing is as follows: standing and balancing in a constant temperature box at 25 ℃ for 1h, mixing semen uniformly at an indefinite period, then placing in a constant temperature box at 17 ℃ for standing and balancing for 2h, and mixing uniformly at an indefinite period;
the specific operation of the constant temperature balance treatment in the step (2) is as follows: standing and balancing in a thermostat at 4 ℃ for 3 hours.
Specifically, in the step (3), the frozen base liquid II is prepared from the following components in parts by weight: 300 parts of glucose, 300 parts of lactose, 400 parts of sodium bicarbonate, 10-15 parts of sodium bicarbonate, 5-7 parts of penicillin sodium, 8-12 parts of streptomycin sulfate, 2200 parts of yolk 1800 and 9000 parts of triple distilled water 7000, wherein the freezing base liquid II further comprises amino-sodium-dodecyl sulfate and glycerol, and the final concentration of the amino-sodium-dodecyl sulfate is 0.50 percent and the final concentration of the glycerol is 3.00 percent according to the volume fraction.
Specifically, in the step (3), before the tubule is placed in liquid nitrogen for preservation, the tubule is fumigated for 10min at a position 3cm above the liquid nitrogen surface.
Specifically, in the step (4), the tubule was taken out of the liquid nitrogen and then placed in a water bath for incubation within 8 seconds.
According to the technical scheme, the beneficial effects of the invention are as follows:
the caffeic acid phenethyl ester is a main active carrier of propolis extract, is a phenolic substance, has wide pharmacological activity, such as antimicrobial, anti-tumor, antioxidant, anticoagulant and the like, and has wide significance in medicine and animal production. In the prior art, caffeic acid phenethyl ester is commonly applied to the following aspects: the caffeic acid phenethyl ester can reduce cardiac hypertrophy and cardiac fibrosis, increase the heart pumping function and reduce the change of tissue morphological hypertrophy; the caffeic acid phenethyl ester can remarkably inhibit the oxidative stress of periodontitis of diabetic rats and the generation of osteoclast and alveolar bone loss induced by RANKL; caffeic acid phenethyl ester may be one of the seed compounds that maintain redox homeostasis; caffeic acid phenethyl ester can inhibit HR-induced H9c2 cell apoptosis and ROS generation in vitro by activating SIRT1/eNOS pathway and inhibiting expression of NF-kB. However, no researchers have heretofore applied it to frozen boar semen.
Hydroxyethyl starch is a modified starch obtained by using amylopectin as a raw material and by chemically reacting it with a hydroxyethyl agent such as ethylene oxide or chlorohydrin to introduce a hydrophilic group hydroxyethyl thereto, and has a high-stability ether bond. During the reaction processes of hydrolysis, oxidation, crosslinking, carboxymethylation and the like, the ether bond is stable and cannot be easily broken, and the influence of pH and electrolyte is small. Hydroxyethyl starch is added into the refrigerating fluid, so that the possibility of destructive osmotic stress is low; in addition, it is non-toxic, so cells can be transplanted after thawing without the need for time-consuming washing steps. Hydroxyethyl starch has been extensively demonstrated to provide good protection in freeze-drying of cells and erythrocytes, but to date there has been no data showing its effect on liquid nitrogen freezing of boar semen.
According to the invention, the caffeic acid phenethyl ester and the hydroxyethyl starch with corresponding concentrations are added into the frozen base solution I in a combined manner, and the synergistic effect of the caffeic acid phenethyl ester and the hydroxyethyl starch can effectively improve the activity, the plasma membrane integrity rate, the acrosome integrity rate and the DNA integrity rate of the thawed pig sperms, thereby improving the quality of the frozen pig sperms.
According to the invention, the caffeic acid phenethyl ester and the hydroxyethyl starch are added into the freezing base liquid I, the frozen base liquid I is firstly adopted to carry out constant temperature balance treatment on the boar semen, so that the caffeic acid phenethyl ester, the hydroxyethyl starch and the boar semen are fully mixed, and then the freezing base liquid II is added, so that the adverse effect of amino-sodium-dodecyl sulfate and glycerol in the freezing base liquid II on the combination effect of the caffeic acid phenethyl ester, the hydroxyethyl starch and the boar semen can be effectively avoided, and the effect of the caffeic acid phenethyl ester and the hydroxyethyl starch is further improved.
The semen protection diluent provided by the invention reduces the damage of the centrifugal action on the activity of the pig semen, and the addition of the semen protection diluent also improves the centrifugal effect of the pig semen and avoids the loss of active ingredients in the pig semen.
Detailed Description
Embodiments of the present invention will be described in detail below with reference to examples, but it will be understood by those skilled in the art that the following examples are only illustrative of the present invention and should not be construed as limiting the scope of the present invention. The examples, in which specific conditions are not specified, were conducted under conventional conditions or conditions recommended by the manufacturer. The reagents or instruments used are not indicated by the manufacturer, and are all conventional products available commercially.
Example 1
A method for improving the quality of thawed pig sperms comprises the following operation steps:
(1) diluting the collected qualified semen by adopting a semen protection diluent within 2 hours, standing and balancing in a constant temperature box at 25 ℃ for 1 hour, uniformly mixing the semen at variable time, then placing in a constant temperature box at 17 ℃ for standing and balancing for 2 hours, uniformly mixing at variable time, and finishing constant temperature balancing; wherein the qualified semen is selected by adopting the following method: selecting semen with slight fishy smell and milky white for microscopic examination, wherein the sperm has the vitality of 90 percent and the density of 2.0-4.0 hundred million/mL and is taken as qualified semen, and the semen protection diluent is prepared from the following components in parts by weight: 1.25 parts of ethylenediamine tetraacetic acid, 1.25 parts of sodium citrate dihydrate, 0.75 part of potassium chloride, 1.25 parts of sodium bicarbonate, 36.50 parts of glucose, 0.60 part of penicillin sodium, 1.00 part of streptomycin sulfate and 1000 parts of triple distilled water, wherein the pH value of the semen protection diluent is 7.3, and the osmotic pressure is 310 mOsm/L;
(2) centrifuging the semen, adding a freezing base solution I into the obtained centrifugal precipitate, and carrying out constant-temperature balance treatment in a constant-temperature box after resuspension, wherein the constant-temperature balance treatment is standing and balancing for 3 hours in the constant-temperature box at 4 ℃, and the freezing base solution I is prepared from the following components in parts by weight: 250 parts of glucose, 350 parts of lactose, 13 parts of sodium bicarbonate, 6 parts of penicillin sodium, 10 parts of streptomycin sulfate, 2000 parts of egg yolk and 8000 parts of triple-distilled water, wherein the frozen base solution I also comprises caffeic acid phenethyl ester and hydroxyethyl starch, the molar concentration of the caffeic acid phenethyl ester in the frozen base solution I is 40 mu mol/L, and the mass fraction of the hydroxyethyl starch in the frozen base solution I is 1.0%;
(3) adding frozen base liquid II to give a final sperm concentration of 5 × 108Mixing, filling into thin tube, sealing, and placing the thin tube inFumigating the part 3cm above the liquid nitrogen surface for 10min, and storing the thin tube in liquid nitrogen, wherein the freezing base liquid II is prepared from the following components in parts by weight: 250 parts of glucose, 350 parts of lactose, 13 parts of sodium bicarbonate, 6 parts of penicillin sodium, 10 parts of streptomycin sulfate, 2000 parts of egg yolk and 8000 parts of triple distilled water, wherein the freezing base liquid II further comprises amino-sodium-dodecyl sulfate and glycerol, and the final concentration of the amino-sodium-dodecyl sulfate is 0.50 percent and the final concentration of the glycerol is 3.00 percent according to the volume fraction;
(4) when the semen is unfrozen, the thin tube is taken out of the liquid nitrogen, the thin tube is placed into a 50 ℃ water bath kettle within 8 seconds to be incubated for 16 seconds, the thin tube is transferred into a 37.0 ℃ preheated semen deposition bottle, and the unfreezing is completed.
Example 2
A method for improving the quality of thawed pig sperms comprises the following operation steps:
(1) diluting the collected qualified semen by adopting a semen protection diluent within 2 hours, standing and balancing in a constant temperature box at 25 ℃ for 1 hour, uniformly mixing the semen at variable time, then placing in a constant temperature box at 17 ℃ for standing and balancing for 2 hours, uniformly mixing at variable time, and finishing constant temperature balancing; wherein the qualified semen is selected by adopting the following method: selecting semen with slight fishy smell and milky white for microscopic examination, wherein the sperm has the vitality of 90 percent and the density of 2.0-4.0 hundred million/mL and is taken as qualified semen, and the semen protection diluent is prepared from the following components in parts by weight: 1.20 parts of ethylenediamine tetraacetic acid, 1.20 parts of sodium citrate dihydrate, 0.70 part of potassium chloride, 1.20 parts of sodium bicarbonate, 36.00 parts of glucose, 0.50 part of penicillin sodium, 0.80 part of streptomycin sulfate and 900 parts of triple distilled water, wherein the pH value of the semen protection diluent is 7.2, and the osmotic pressure is 300 mOsm/L;
(2) centrifuging the semen, adding a freezing base solution I into the obtained centrifugal precipitate, and carrying out constant-temperature balance treatment in a constant-temperature box after resuspension, wherein the constant-temperature balance treatment is standing and balancing for 3 hours in the constant-temperature box at 4 ℃, and the freezing base solution I is prepared from the following components in parts by weight: 200 parts of glucose, 300 parts of lactose, 10 parts of sodium bicarbonate, 5 parts of penicillin sodium, 8 parts of streptomycin sulfate, 1800 parts of egg yolk and 7000 parts of triple-distilled water, wherein the frozen base solution I also comprises caffeic acid phenethyl ester and hydroxyethyl starch, the molar concentration of the caffeic acid phenethyl ester in the frozen base solution I is 30 mu mol/L, and the mass fraction of the hydroxyethyl starch in the frozen base solution I is 0.8%;
(3) adding frozen base liquid II to give final concentration of 4 × 108Uniformly mixing the components per mL, filling the mixture into a thin tube, sealing the tube, fumigating the thin tube at a position 3cm above a liquid nitrogen surface for 10min, and putting the thin tube into liquid nitrogen for storage, wherein the freezing base liquid II is prepared from the following components in parts by weight: 200 parts of glucose, 300 parts of lactose, 10 parts of sodium bicarbonate, 5 parts of penicillin sodium, 8 parts of streptomycin sulfate, 1800 parts of egg yolk and 7000 parts of triple distilled water, wherein the freezing base liquid II further comprises amino-sodium-dodecyl sulfate and glycerol, and the final concentration of the amino-sodium-dodecyl sulfate is 0.50 percent and the final concentration of the glycerol is 3.00 percent according to the volume fraction;
(4) when the semen is unfrozen, the thin tube is taken out of the liquid nitrogen, the thin tube is placed into a water bath kettle at 48 ℃ within 8 seconds for incubation for 15 seconds, the thin tube is transferred into a 36.9 ℃ preheated semen deposition bottle, and the unfreezing is completed.
Example 3
A method for improving the quality of thawed pig sperms comprises the following operation steps:
(1) diluting the collected qualified semen by adopting a semen protection diluent within 2 hours, standing and balancing in a constant temperature box at 25 ℃ for 1 hour, uniformly mixing the semen at variable time, then placing in a constant temperature box at 17 ℃ for standing and balancing for 2 hours, uniformly mixing at variable time, and finishing constant temperature balancing; wherein the qualified semen is selected by adopting the following method: selecting semen with slight fishy smell and milky white for microscopic examination, wherein the sperm has the vitality of 90 percent and the density of 2.0-4.0 hundred million/mL and is taken as qualified semen, and the semen protection diluent is prepared from the following components in parts by weight: 1.30 parts of ethylenediamine tetraacetic acid, 1.30 parts of sodium citrate dihydrate, 0.80 part of potassium chloride, 1.30 parts of sodium bicarbonate, 37.00 parts of glucose, 0.70 part of penicillin sodium, 1.20 parts of streptomycin sulfate and 1100 parts of triple distilled water, wherein the pH value of the semen protection diluent is 7.4, and the osmotic pressure is 320 mOsm/L;
(2) centrifuging the semen, adding a freezing base solution I into the obtained centrifugal precipitate, and carrying out constant-temperature balance treatment in a constant-temperature box after resuspension, wherein the constant-temperature balance treatment is standing and balancing for 3 hours in the constant-temperature box at 4 ℃, and the freezing base solution I is prepared from the following components in parts by weight: 300 parts of glucose, 400 parts of lactose, 15 parts of sodium bicarbonate, 7 parts of penicillin sodium, 12 parts of streptomycin sulfate, 2200 parts of egg yolk and 9000 parts of triple distilled water, wherein the frozen base solution I also comprises caffeic acid phenethyl ester and hydroxyethyl starch, the molar concentration of the caffeic acid phenethyl ester in the frozen base solution I is 50 mu mol/L, and the mass fraction of the hydroxyethyl starch in the frozen base solution I is 1.2%;
(3) adding frozen base liquid II to give final concentration of 8 × 108Uniformly mixing the components per mL, filling the mixture into a thin tube, sealing the thin tube, freezing the thin tube by using a program freezer, and then putting the thin tube into liquid nitrogen for preservation, wherein the freezing base liquid II is prepared from the following components in parts by weight: 300 parts of glucose, 400 parts of lactose, 15 parts of sodium bicarbonate, 7 parts of penicillin sodium, 12 parts of streptomycin sulfate, 2200 parts of yolk and 9000 parts of triple distilled water, wherein the freezing base liquid II further comprises amino-sodium-dodecyl sulfate and glycerol, and the final concentration of the amino-sodium-dodecyl sulfate is 0.50 percent and the final concentration of the glycerol is 3.00 percent according to the volume fraction;
(4) when the semen is unfrozen, the thin tube is taken out of the liquid nitrogen, the thin tube is placed into a 52 ℃ water bath kettle for incubation for 17s within 8 seconds, the thin tube is transferred into a 37.1 ℃ preheated semen deposition bottle, and the unfreezing is completed.
Comparative example 1
The same procedures as in example 1 were repeated except that the caffeic acid phenethyl ester in the frozen base solution I was replaced with the same amount of chlorogenic acid.
Comparative example 2
The same procedure as in example 1 was repeated except that the hydroxyethyl starch in the frozen base liquid I was replaced with the same amount of polyvinylpyrrolidone.
Comparative example 3
Amino-sodium lauryl sulfate and glycerol were added to the frozen base liquid i in a final concentration of 0.50% by volume and 3.00% by volume, and the remaining operation was exactly the same as in example 1.
The method of each embodiment and the method of the comparative example are respectively used for carrying out thawing treatment after freezing the semen of the same Songliao black pig, and then the sperm motility, the plasma membrane integrity rate, the acrosome integrity rate and the DNA integrity rate of the thawed pig semen are tested, wherein:
pig sperm motility was detected by computer-aided sperm analysis system (CASA).
Many studies have shown that sperm metabolism, acrosome reaction, capacitation, and sperm-egg fusion are closely related to the functional integrity of the sperm membrane, and thus one of the important indicators for evaluating sperm fertilization ability is the functional integrity of the sperm membrane. The sperm membrane is an important barrier for the separation of the interior and exterior of the sperm and also contains important pathways for the sperm to communicate between the interior and exterior, affecting metabolism and vital functions by receiving signals transmitted intracellularly and extracellularly by the sperm, and therefore, the integrity of the sperm plasma membrane is essential for the sperm to perform normal vital functions. The invention uses the low permeability swelling test (HOST) to test the integrity of the sperm plasma membrane, the defrosted semen is mixed with fructose-sodium citrate hypotonic solution preheated at 37 ℃ to make the semen concentration 5X 106At least 200 sperms are counted and repeated for more than 5 times, and the sperm plasma membrane integrity rate (%) is the sperm with bent tail/the total sperm count multiplied by 100%.
Acrosome integrity is a necessary condition for spermatogenesis acrosome reaction, and defects or dysfunction of acrosome structure are closely related to animal reproduction problems. The invention uses a fluorescein isothiocyanate (peanut agglutinin, FITC-PNA) fluorescence staining method to detect. After thawing, 1mL of PBS (phosphate buffered saline) preheated at 37 ℃ was added to the semen, and the mixture was centrifuged at 2400r/min for 5min by using a temperature-controlled centrifuge, and the precipitate was left, and then resuspended in PBS, and the process was repeated three times. Adjusting semen concentration with PBS for the last time to maintain semen density at 5 × 106Mixing at about one/mL, spreading 30 μ L onto glass slide, and air dryingThen evenly smearing with methanol, fixing at room temperature for 10min, then evenly smearing 30 μ L FITC-PNA dye solution on a glass slide in dark environment, putting the glass slide into a 37 ℃ wet cassette for incubation for 30min, slowly washing with PBS, and naturally drying in the dark environment. No less than 200 sperm cells were counted under a 200 Xfluorescence microscope with excitation light at 480nm and emission light at 530 nm. Sperm with intact acrosomes fluoresced green, the fluorescent portion was cap-shaped, each test was repeated more than 5 times, and the sperm acrosome integrity (%) was equal to sperm with intact acrosomes/total sperm count x 100%.
DNA is a biological macromolecule necessary for the growth and development of organisms and for normal life activities. The invention uses AO fluorescence staining method to detect sperm DNA integrity. The sperm pretreatment and acrosome integrity rate detection are carried out, the thawed semen is washed for three times by PBS, and the sperm concentration is kept at 5 multiplied by 106About one per mL, uniformly coating 30 mu L of the mixture on a glass slide, naturally drying, fixing for 3h by using absolute ethyl alcohol-glacial acetic acid (3:1), placing the glass slide in a newly prepared AO dye solution in a dark environment for 10min, slowly washing by using PBS, naturally drying in the dark, and adding paraffin oil for sealing. The number of sperm was counted under a 200 Xfluorescence microscope at not less than 200, excitation light at 480nm, and emission light at 530 nm. DNA-intact sperm fluoresced green, DNA-damaged sperm fluoresced yellow or even red, and each set of experiments was repeated more than 5 times with a percent (%) intact sperm DNA (%) -intact sperm DNA/total sperm count x 100%.
The test results are shown in table 1:
as can be seen from Table 1, the method for improving the quality of the thawed pig sperms, provided by the invention, can effectively improve the quality of the thawed pig sperms after the caffeic acid phenethyl ester and the hydroxyethyl starch are used in combination; the method comprises the steps of firstly adopting the freezing base solution I to carry out constant-temperature balance treatment on the boar semen so that the caffeic acid phenethyl ester, the hydroxyethyl starch and the boar semen are fully mixed, and then adding the freezing base solution II, so that the adverse effect of amino-sodium-dodecyl sulfate and glycerol in the freezing base solution II on the combination effect of the caffeic acid phenethyl ester, the hydroxyethyl starch and the boar semen can be effectively avoided.
The embodiments described above are some, but not all embodiments of the invention. The detailed description of the embodiments of the present invention is not intended to limit the scope of the invention as claimed, but is merely representative of selected embodiments of the invention. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.
Claims (6)
1. The method for improving the quality of the thawed pig sperms is characterized by comprising the following operation steps:
(1) diluting the collected qualified semen by a semen protection diluent, and then carrying out constant temperature balance treatment;
(2) centrifuging the semen, adding a freezing base solution I into the obtained centrifugal precipitate, and carrying out constant-temperature balance treatment in a constant-temperature box after resuspension, wherein the freezing base solution I is prepared from the following components in parts by weight: 300 parts of glucose, 300 parts of lactose, 400 parts of sodium bicarbonate, 10-15 parts of sodium bicarbonate, 5-7 parts of penicillin sodium, 8-12 parts of streptomycin sulfate, 2200 parts of yolk 1800, and 9000 parts of triple distilled water 7000, wherein the frozen base liquid I further comprises phenethyl caffeate and hydroxyethyl starch, the molar concentration of the phenethyl caffeate in the frozen base liquid I is 30-50 mu mol/L, and the mass fraction of the hydroxyethyl starch in the frozen base liquid I is 0.8-1.2%;
(3) adding frozen base liquid II to give final concentration of 4 × 108-8×108Uniformly mixing, filling into a thin tube, sealing, and then putting into liquid nitrogen for preservation;
(4) when the semen is unfrozen, taking out the thin tube from the liquid nitrogen, incubating the thin tube in a water bath kettle at 48-52 ℃ for 15-17s, transferring the thin tube into a 36.9-37.1 ℃ preheated semen infusion bottle, adding unfreezing diluent, and completing unfreezing;
the semen protection diluent is prepared from the following components in parts by weight: 1.20-1.30 parts of ethylenediamine tetraacetic acid, 1.20-1.30 parts of sodium citrate dihydrate, 0.70-0.80 part of potassium chloride, 1.20-1.30 parts of sodium bicarbonate, 36.00-37.00 parts of glucose, 0.50-0.70 part of penicillin sodium, 0.80-1.20 parts of streptomycin sulfate and 1100 parts of triple distilled water, wherein the pH value of the semen protection diluent is 7.2-7.4, and the osmotic pressure is 320mOsm/L of 300-;
in the step (3), the freezing base liquid II is prepared from the following components in parts by weight: 300 parts of glucose, 300 parts of lactose, 400 parts of sodium bicarbonate, 10-15 parts of sodium bicarbonate, 5-7 parts of penicillin sodium, 8-12 parts of streptomycin sulfate, 2200 parts of yolk 1800 and 9000 parts of triple distilled water 7000, wherein the freezing base liquid II further comprises amino-sodium-dodecyl sulfate and glycerol, and the final concentration of the amino-sodium-dodecyl sulfate is 0.50 percent and the final concentration of the glycerol is 3.00 percent according to the volume fraction.
2. The method of claim 1, wherein the semen is collected from the boar and filled in an incubator, and diluted with a semen protection diluent within 2 hours.
3. The method according to claim 1, wherein in the step (1), the qualified semen is selected by the following method: selecting slightly fishy and milky semen to perform microscopic examination, wherein the vitality of the semen is 90 percent, and the density of the semen is 2.0-4.0 hundred million/mL, so that the qualified semen is obtained.
4. The method for improving the quality of thawed pig sperm according to claim 1, wherein in the step (1), the specific operation of the constant temperature equilibration treatment is as follows: standing and balancing in a constant temperature box at 25 ℃ for 1h, mixing semen uniformly at an indefinite period, then placing in a constant temperature box at 17 ℃ for standing and balancing for 2h, and mixing uniformly at an indefinite period;
the specific operation of the constant temperature balance treatment in the step (2) is as follows: standing and balancing in a thermostat at 4 ℃ for 3 hours.
5. The method according to claim 1, wherein in step (3), the tubule is fumigated at a position 3cm above the liquid nitrogen surface for 10min before being stored in liquid nitrogen.
6. The method according to claim 1, wherein in step (4), the thin tube is taken out of the liquid nitrogen and then placed in a water bath for incubation within 8 seconds.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010745843.XA CN111771873B (en) | 2020-07-29 | 2020-07-29 | Method for improving quality of thawed pig sperms |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010745843.XA CN111771873B (en) | 2020-07-29 | 2020-07-29 | Method for improving quality of thawed pig sperms |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN111771873A CN111771873A (en) | 2020-10-16 |
| CN111771873B true CN111771873B (en) | 2021-12-21 |
Family
ID=72765464
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202010745843.XA Expired - Fee Related CN111771873B (en) | 2020-07-29 | 2020-07-29 | Method for improving quality of thawed pig sperms |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN111771873B (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113317312B (en) * | 2021-06-01 | 2022-07-12 | 福建农林大学 | Diluent preparation capable of prolonging normal-temperature survival period of boar semen |
| CN115141797B (en) * | 2022-07-26 | 2024-02-20 | 华中农业大学 | Frozen semen thawing agent for pigs and preparation method thereof |
| CN117158415B (en) * | 2023-11-02 | 2024-02-02 | 黑龙江八一农垦大学 | Pig sperm cryopreservation diluent containing iramate and application thereof |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5849473A (en) * | 1991-02-15 | 1998-12-15 | Cobe Laboratories, Inc. | Method of lyophilization of mammalian sperm cells |
| WO2011105633A1 (en) * | 2010-02-26 | 2011-09-01 | Ajinomoto Co., Inc. | Virus-inactivating composition containing low-molecular weight compound and arginine |
| KR101403597B1 (en) * | 2012-11-28 | 2014-06-03 | 대한민국 | Composition for cryopreservation of semen |
| ES2530427A1 (en) * | 2013-09-02 | 2015-03-02 | Univ Extremadura | Diluent for the freezing of semen equine adaptable to each individual (Machine-translation by Google Translate, not legally binding) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007146344A2 (en) * | 2006-06-12 | 2007-12-21 | The Jackson Laboratory | Sperm cryoprotective media |
| US20160338354A1 (en) * | 2015-05-19 | 2016-11-24 | Valent Biosciences Corporation | (s)-abscisic acid derivatives for enhanced fruit and vegetable coloration |
-
2020
- 2020-07-29 CN CN202010745843.XA patent/CN111771873B/en not_active Expired - Fee Related
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5849473A (en) * | 1991-02-15 | 1998-12-15 | Cobe Laboratories, Inc. | Method of lyophilization of mammalian sperm cells |
| WO2011105633A1 (en) * | 2010-02-26 | 2011-09-01 | Ajinomoto Co., Inc. | Virus-inactivating composition containing low-molecular weight compound and arginine |
| KR101403597B1 (en) * | 2012-11-28 | 2014-06-03 | 대한민국 | Composition for cryopreservation of semen |
| ES2530427A1 (en) * | 2013-09-02 | 2015-03-02 | Univ Extremadura | Diluent for the freezing of semen equine adaptable to each individual (Machine-translation by Google Translate, not legally binding) |
Non-Patent Citations (1)
| Title |
|---|
| Ayla 等.Antioxidant activity of CAPE (caffeic acid phenethyl ester) in vitro can protect human sperm deoxyribonucleic acid from oxidative damageAntioxidant activity of CAPE.《ACTA HISTOCHEMICA》.2018,(第120期),117-121. * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN111771873A (en) | 2020-10-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN111771873B (en) | Method for improving quality of thawed pig sperms | |
| Piper et al. | Culturing of calcium stable adult cardiac myocytes | |
| Surai et al. | Poultry artificial insemination technology in the countries of the former USSR | |
| Borei | Respiration of oocytes, unfertilized eggs and fertilized eggs from Psammechinus and Asterias | |
| Ustuner et al. | Effect of rainbow trout (Oncorhynchus mykiss) seminal plasma on the post-thaw quality of ram semen cryopreserved in a soybean lecithin-based or egg yolk-based extender | |
| New | Studies on mammalian fetuses in vitro during the period of organogenesis | |
| US20020131957A1 (en) | Cryopreservation of sperm | |
| Chang | The effects of low temperature on fertilized rabbit ova in vitro, and the normal development of ova kept at low temperature for several days | |
| Wong et al. | The role of angiotensin-converting enzyme in the rat epididymis | |
| Amidi et al. | Effects of cholesterol-loaded cyclodextrin during freezing step of cryopreservation with TCGY extender containing bovine serum albumin on quality of goat spermatozoa | |
| Daramola et al. | Effects of coconut (Cocos nucifera) water with or without egg-yolk on viability of cryopreserved buck spermatozoa | |
| López-Damián et al. | Cryopreservation induces higher oxidative stress levels in Bos indicus embryos compared with Bos taurus | |
| CN111657266B (en) | Application of phloretin in preparation of porcine, sheep or cattle semen cryopreservation agent | |
| Mansour et al. | Characterization of the testicular semen of the African catfish, Clarias gariepinus (Burchell, 1822), and its short‐term storage | |
| Pugh et al. | Cryopreservation of in vitro-produced bovine embryos: effects of protein type and concentration during freezing or of liposomes during culture on post-thaw survival | |
| Lutwak-Mann et al. | Metabolic activity in tissue transplants. Hormone-induced formation of fructose and citric acid in transplants from accessory glands of reproduction | |
| Hootman et al. | Dissociation of avian salt gland: separation procedures and characterization of dissociated cells | |
| CN115119833B (en) | Semen cryopreservation diluent and application thereof | |
| Ponce et al. | Functional activity of epididymal Chinchilla laniger spermatozoa cryopreserved in different extenders | |
| Bebas et al. | The use of lactose-astaxanthin to maintain the quality of green junglefowl frozen semen | |
| CN106993605A (en) | A kind of down producing goat freezing seminal fluid dilution formula | |
| CN115624024B (en) | Application of codonopsis pilosula polysaccharide as additive in sheep semen low-temperature diluent | |
| CN115119828B (en) | Diluent for refrigerating and preserving canine sperms and preparation method and application thereof | |
| CN113812396B (en) | Duck essence cryopreservation diluent | |
| CN112056305B (en) | Balanced vitrification freezing reagent and application thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20211221 |